• Profile
Close

Changes in kidney function associated with daily tenofovir disoproxil fumarate/emtricitabine for HIV preexposure prophylaxis use in the United States Demonstration Project

Journal of Acquired Immune Deficiency Syndromes Jan 23, 2018

Tang EC, et al. - Researchers here investigated kidney function associated with HIV preexposure prophylaxis (PrEP) using daily oral tenofovir-disoproxil-fumarate/emtricitabine in real-world clinical settings. Daily tenofovir-disoproxil-fumarate/emtricitabine PrEP resulted in reduced creatinine clearance and estimated glomerular filtration rate (eGFR). However, these eGFR changes were based on very small changes in serum creatinine and appeared to be nonprogressive after the first 12 weeks.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay